Tamoxifen and risk of large bowel cancer in women with breast cancer

被引：0
作者：
Polly A. Newcomb
Cam Solomon
Emily White
机构：
[1] Fred Hutchinson Cancer Research Center,Cancer Prevention Research Program
来源：
Breast Cancer Research and Treatment | 1999年 / 53卷
关键词：
breast neoplasms; therapy; colorectal neoplasms; estrogen antagonists; estrogen replacement therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background: The increasingly consistent association between estrogen replacement therapy and colorectal cancer suggests that the anti-estrogen tamoxifen may also be associated with large bowel cancer incidence.
引用
收藏
页码：271 / 277
页数：6
相关论文
共 50 条
[21]   A prospective, randomized study on hepatotoxicity of anastrozole compared with tamoxifen in women with breast cancer [J].
Lin, Ying ;
Liu, Jianlun ;
Zhang, Xiaohua ;
Li, Li ;
Hu, Rui ;
Liu, Jian ;
Deng, Yongchuan ;
Chen, Dedian ;
Zhao, Yangbing ;
Sun, Shengrong ;
Ma, Rong ;
Zhao, Ying ;
Liu, Jinping ;
Zhang, Yang ;
Wang, Xijing ;
Li, Yafen ;
He, Pingqing ;
Li, Enxiao ;
Xu, Zheli ;
Wu, Yaqun ;
Tong, Zhongsheng ;
Wang, Xiaojia ;
Huang, Tao ;
Liang, Zhongxiao ;
Wang, Shui ;
Su, Fengxi ;
Lu, Yunfei ;
Zhang, Helong ;
Feng, Guosheng ;
Wang, Shenming .
CANCER SCIENCE, 2014, 105 (09) :1182-1188
[22]   Aromatase inhibitors and the risk of colorectal cancer in postmenopausal women with breast cancer [J].
Khosrow-Khavar, F. ;
Yin, H. ;
Barkun, A. ;
Bouganim, N. ;
Azoulay, L. .
ANNALS OF ONCOLOGY, 2018, 29 (03) :744-748
[23]   The effect of tamoxifen on estradiol, SHBG, IGF-1, and CRP in women with breast cancer or at risk of developing breast cancer: a meta-analysis of randomized controlled trials [J].
Li, Xingda ;
Hou, Xuejiao ;
Hernandez-Wolters, Benjamin ;
Hern, Benjamin ;
Prabahar, Kousalya ;
Kord-Varkaneh, Hamed ;
Mei, Bo .
EXPERIMENTAL GERONTOLOGY, 2024, 191
[24]   MR imaging appearance of the uterus in postmenopausal women receiving tamoxifen therapy for breast cancer: Histopathologic correlation [J].
Ascher, SM ;
Johnson, JC ;
Barnes, WA ;
Bae, CJ ;
Patt, RH ;
Zeman, RK .
RADIOLOGY, 1996, 200 (01) :105-110
[25]   Breast Cancer Screening in Women at Average Risk and High Risk [J].
Griffin, Jennifer L. ;
Pearlman, Mark D. .
OBSTETRICS AND GYNECOLOGY, 2010, 116 (06) :1410-1421
[26]   Aromatase inhibitors, tamoxifen, and endometrial cancer in breast cancer survivors [J].
Chlebowski, Rowan T. ;
Schottinger, Joanne E. ;
Shi, Jiaxiao ;
Chung, Joanie ;
Haque, Reina .
CANCER, 2015, 121 (13) :2147-2155
[27]   Tamoxifen in the adjuvant setting for breast cancer: Reflexions about the risk of uterine carcinosarcoma [J].
Leung, F. ;
Terzibachian, J. -J. ;
Govyadovskiy, A. ;
Bourtembourg, A. ;
Maillet, R. ;
Riethmuller, D. .
GYNECOLOGIE OBSTETRIQUE & FERTILITE, 2009, 37 (05) :447-451
[28]   Tamoxifen treatment for male breast cancer and risk of thromboembolism: prospective cohort analysis [J].
Eggemann, Holm ;
Bernreiter, Anna-Lena ;
Reinisch, Mattea ;
Loibl, Sibylle ;
Taran, Florin-Andrei ;
Costa, Serban-Dan ;
Ignatov, Atanas .
BRITISH JOURNAL OF CANCER, 2019, 120 (03) :301-305
[29]   Breast cancer recurrence risk related to concurrent use of SSRI antidepressants and tamoxifen [J].
Lash, Timothy L. ;
Cronin-Fenton, Deirdre ;
Ahern, Thomas P. ;
Rosenberg, Carol L. ;
Lunetta, Kathryn L. ;
Silliman, Rebecca A. ;
Hamilton-Dutoit, Stephen ;
Garne, Jens Peter ;
Ewertz, Marianne ;
Sorensen, Henrik Toft ;
Pedersen, Lars .
ACTA ONCOLOGICA, 2010, 49 (03) :305-312
[30]   Breast Cancer Risk Prediction in Korean Women: Review and Perspectives on Personalized Breast Cancer Screening [J].
Kim, Do Yeun ;
Park, Hannah Lui .
JOURNAL OF BREAST CANCER, 2020, 23 (04) :331-342
12345